The South African Ministry of Health said today, Sunday, that the authorities have sold the “AstraZeneca” anti-corona vaccine that it obtained and did not use to other countries of the African Union.
The country had suspended vaccination with the aforementioned vaccine last month due to “a small trial that showed that the vaccine provides limited protection against infection with the common strain of Covid-19 in South Africa.”
Meanwhile, the country has received one million doses of the company’s vaccine from the Indian “Serum” Institute of Serum and Vaccine, and is awaiting receipt of another 500,000 doses.
The ministry said that it had worked in recent weeks to ensure that all Member States, which the AU Vaccine Purchase Team considered to be recipients of the vaccine, had obtained all the approvals and permits required to launch the vaccine on their soil.
“The ministry can confirm that it received the purchased quantity in full on Monday of last week,” the ministry said in a statement.
“The first batch of the vaccine that we received will benefit nine member states, and the remainder will be delivered this week to benefit five other countries,” she added.
After stopping the use of the AstraZeneca vaccine, South Africa began vaccinating medical workers with the Johnson & Johnson vaccine.